Introducing a new journal NE W Aims & Scope Bladder Cancer is an international multidisciplinary journal to facilitate progress in understanding the epidemiology/etiology, genetics, molecular correlates, pathogenesis, pharmacology, ethics, patient advocacy and survivorship, diagnosis and treatment of tumors of the bladder and upper urinary tract. The journal publishes research reports, reviews, short communications, and letters-to-the-editor. In addition, the journal will also have a “News and Views” section for timely commentary. The journal is dedicated to providing an open forum for original research in basic science, translational research and clinical medicine that will expedite our fundamental understanding and improve treatment of tumors of the bladder and upper urinary tract. Editors-in-Chief Associate Editors Seth P. Lerner Scott Department of Urology Baylor College of Medicine Houston, Texas, USA Email: blc@iospress.com Joaquim Bellmunt, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA Jason A. Efstathiou, Massachusetts General Hospital, Harvard Medical School, Boston, USA Donna Hansel, University of California, San Diego, San Diego, USA Maha Hussain, University of Michigan, Ann Arbor, USA Cheryl Lee, University of Michigan, Ann Arbor, USA David McConkey, The University of Texas MD Anderson Cancer Center, Houston, USA Matt Milowsky, University of North Carolina, Chapel Hill, USA Torben Ørntoft, Aarhus University Hospital, Aarhus, Denmark Diane Zipursky Quale, BCAN, Bethesda, USA Francisco X. Real, CNIO, Madrid, Spain George Thalmann, University of Bern, Bern, Switzerland Xue-Ru Wu, New York University (NYU), New York, USA Alexandre R. Zlotta, Mount Sinai Hospital, Toronto, Canada; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada Ellen Zwarthoff, Erasmus MC, Rotterdam, The Netherlands Dan Theodorescu University of Colorado Cancer Center Aurora, Colorado, USA Email: blc@iospress.com Associate Editors for Reviews Georgios Gakis, University Hospital Tübingen, Tübingen, Germany Matthew Galsky, Mount Sinai Hospital, New York, USA Call for Papers Submit Your Article Submit manuscripts electronically via the msTracker online submission system at: http://mstracker.com/submit1.php?jc=blc For detailed instructions please visit our website: www.iospress.com/bladder-cancer/?tab=submission-of-manuscripts www.iospress.com/bladder-cancer Editors of Clinical Trials Corner Piyush K. Agarwal, National Cancer Institute, Bethesda, USA Cora N. Sternberg, San Camillo and Forlanini Hospitals, Roma, Italy Editorial Board Cory Abate-Shen, Columbia University, New York, USA Hikmat Al-Ahmadie, Memorial Sloan-Kettering Cancer Center, New York, USA Matthew L. Albert, Institut Pasteur, Paris, France Ajjai Alva, University of Michigan, Ann Arbor, USA Andrea Apolo, National Cancer Institute, Rockville, USA Jessie Au, Optimum Therapeutics, LLC, Columbus, USA Marko Babjuk, Motol Teaching Hospital, Prague, Czech Republic Rick Bangs, Patient Advocate, Rochester Hills, USA Trinity Bivalacqua, Johns Hopkins Medicine, Baltimore, USA Peter Black, Vancouver Prostate Centre, Vancouver, Canada Bernard Bochner , Memorial Sloan-Kettering Cancer Center, New York, USA James Catto, The University of Sheffield, Sheffield, United Kingdom Karim Chamie, University of California Los Angeles, Los Angeles, USA Keith Syson Chan, Baylor College of Medicine, Houston, USA Sam Chang, Vanderbilt University, Nashville, USA Liang Cheng, Indiana University, Indianapolis, USA Richard J. Cote, University of Miami Miller School of Medicine, Miami, USA Bogdan Czerniak, University of Texas, Austin, USA Sia Daneshmand, University of Southern California, Los Angeles, USA Ian D. Davis, Monash University and Eastern Health, Melbourne, Australia Colin P. Dinney, University of Texas, Houston, USA Lars Dyrskjøt Andersen, Aarhus University, Aarhus, Denmark Thomas Flaig, University of Colorado, Boulder, USA John Gore, University of Washington, Seattle, USA Susan Groshen, University of Southern California, Los Angeles, USA Noah Hahn, Johns Hopkins Medicine, Baltimore, USA Richard Hautmann, Universität Ulm, Ulm, Germany Jean Hoffman-Censits, Thomas Jefferson University, Philadelphia, USA Molly Ingersoll, Institut Pasteur, Paris, France Ashish M. Kamat, University of Texas, Austin, USA Lawrence Karsh, The Urology Center of Colorado, Denver, USA Wassim Kassouf, McGill University Health Center, Montreal, Canada Bart Kiemeney, Radboud University, Nijmegen, The Netherlands Anne Kiltie, University of Oxford, Oxford, United Kingdom William Kim, University of North Carolina, Wilmington, USA Margaret Knowles, University of Leeds, Leeds, United Kingdom Badrinath Konety, University of Minnesota, Minneapolis, USA David J. Kwiatkowski, Harvard Medical School, Boston, USA Donald Lamm, University of Arizona, Phoenix, USA David Latini, Michael DeBakey Medical Center, Houston, USA Nathan Lawrentschuk, University of Melbourne, Victoria, Australia Vinata Lokeshwar, University of Miami, Miami, USA Yair Lotan, UT Southwestern Medical Center, Dallas, USA Nuria Malats, CNIO, Madrid, Spain Surena Matin, University of Texas, Austin, USA Kazumasa Matsumoto, Kitasato University, Kanagawa, Japan James McKiernan, Columbia University, New York, USA IOS Press Nieuwe Hemweg 6B 1013 BG Amsterdam The Netherlands Tel.: +31 20 688 3355 Fax: +31 20 687 0019 Email: market@iospress.com Maxwell Meng, University of California San Francisco, San Francisco, USA Anirban P. Mitra, University of Southern California, Los Angeles, USA Ofer Nativ, Bnai Zion Medical Center, Haifa, Israel Matthew Nielsen, University of North Carolina, Chapel Hill, USA Hiroyuki Nishiyama, University of Tsukuba, Tsukuba, Japan Tim O'Brien, Guy’s and St Thomas’, London, United Kingdom Mike A. O'Donnell, University of Iowa Carver College of Medicine, Iowa City, USA Howard Parnes, NIH, Bethesda, USA Dan Petrylak, Yale University, New Haven, USA Betsy Plimack, Fox Chase Cancer Center, Philadelphia, USA Kamal Pohar, Ohio State University, Columbus, USA Mike Porter, University of Washington, Seattle, USA David Quinn, University of Southern California, Los Angeles, USA Derek Raghavan, Levine Cancer Institute, Charlotte, USA Joan Palou Redorta, Universitat Autónoma de Barcelona, Barcelona, Spain Cyrill Rentsch, University Hospital of Basel, Basel, Switzerland Bas W.G. van Rhijn, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands Jonathan Rosenberg, Memorial Sloan-Kettering Cancer Center, New York, USA Arthur I. Sagalowsky, UT Southwestern, Dallas, USA Maria De Santis, Kaiser-Franz-Josef-Spital, Vienna, Austria Bernd J. Schmitz-Drager, EuroMed Clinic, Fürth, Germany Mark P. Schoenberg, The Albert Einstein College of Medicine & The Montefiore Medical Center, New York, USA Shahrokh F. Shariat, Medical University Vienna, Vienna, Austria Eila C. Skinner, Stanford University, Stanford, USA Carolyn Smith, Baylor College of Medicine, Houston, USA Norm Smith, University of Chicago, Chicago, USA Walt Stadler, University of Chicago, Chicago, USA Gary Steinberg, University of Chicago, Chicago, USA Arnulf Stenzl, Universitätsklinikum Tübingen, Tübingen, Germany Seth Strope, Washington University, St. Louis, USA Robert Svatek, University of Texas, San Antonio, USA Antonia Vlahou, Biomedical Research Foundation Academy of Athens, Athens, Greece Nick Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, USA Fred A.J. Witjes, Radboud University Nijmegen, Nijmegen, The Netherlands Statistical and Bioinformatics Editorial Board Edward J. Bedrick, University of Colorado, Boulder, USA Debashis Ghosh, University of Colorado, Boulder, USA Michael C. Sachs, NIH, Bethesda, USA Richard Sylvester, EORTC, Brussels, Belgium Jeremy Taylor, University of Michigan, Ann Arbor, USA Journal Information ISSN 2352-3727 (print) ISSN 2352-3735 (online) The first issue (1:1) to be published in 2015 Open Access author fees waived for 2015 and 2016 First two years freely available online (2015 and 2016) IOS Press, Inc. 6751 Tepper Drive Clifton, VA 20124 USA Tel.: +1 703-830-6300 Fax: +1 703-830-2300 Email: sales@iospress.com
© Copyright 2024